Researchers Turn to Sequencing to Study Genetic Underpinnings of Drug Response
April 05, 2011
Researchers Turn to Sequencing to Study Genetic Underpinnings of Drug Response
"Looking at drug-response genetics and looking at disease genetics are very parallel processes," said Ron Krauss, senior scientist and director of atherosclerosis research at Children's Hospital Oakland Research Institute in California.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News - TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News - Exome Sequencing IDs Druggable BRAF Mutation in 47 HCL Patients
June 15, 2011 / Clinical Sequencing News - Exome Sequencing of Metastatic Melanoma IDs Mutations in Pathway with Clinical Significance
April 19, 2011 / Clinical Sequencing News - NHGRI To Fund Exome Sequencing of Mendelian Disorders Under Global Rare Disease Consortium
April 12, 2011 / Clinical Sequencing News